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Summary
Degeneration of skeletal muscle (SkM) with age (sarcopenia) is a
major contributor to functional decline, morbidity and mortality.
Methodological implications often make it difficult to embark on
interventions in already frail and diseased elderly individuals.
Using in vitro three-dimensional (3D) bioengineered skeletal
muscle constructs that model aged phenotypes and incorporate a
representative extracellular matrix (collagen), are under tension,
and display morphological and transcript expression of mature
skeletal muscle may more accurately characterize the SkM niche.
Furthermore, an in vitromodel would provide greater experimen-
tal manipulation with regard to gene, pharmacological and
exercise (mechanical stretch ⁄ electrical stimulation) therapies and
thus strategies for combating muscle wasting with age. The pres-
ent study utilized multiple population-doubled (MPD) murine
myoblasts compared with parental controls (CON), previously
shown to have an aged phenotype in monolayer cultures (Shar-
ples et al., 2011), seeded into 3D type I collagen matrices under
uniaxial tension. 3D bioengineered constructs incorporating MPD
cells had reduced myotube size and diameter vs. CON constructs.
MPD constructs were characterized by reduced peak force
development over 24 h after cell seeding, reduced transcript
expression of remodelling matrix metalloproteinases, MMP2 and
MMP9, with reduced differentiation ⁄hypertrophic potential
shown by reduced IGF-I, IGF-IR, IGF-IEa, MGF mRNA. Increased
IGFBP2 and myostatin in MPD vs. CON constructs also suggested
impaired differentiation ⁄ reduced regenerative potential. Overall,
3D bioengineered skeletal muscle constructs represent an in vitro
model of the in vivo cell niche with MPD constructs displaying
similar characteristics to ageing ⁄ atrophied muscle in vivo, thus
potentially providing a future test bed for therapeutic interven-
tions to contest muscle degeneration with age.
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Introduction
After the age of 50, humans lose skeletal muscle (SkM) mass at a rate of
1–2% per year (Hughes et al., 2001). This phenomenon (sarcopenia)
(Rosenberg, 1997) is a significant contributor to the loss of metabolic
function (Russ & Lanza, 2011), physiological capacity and is strongly cor-
related with morbidity and mortality (Rantanen et al., 2000). Sarcopenia
is now recognized as a serious clinical disorder (Cruz-Jentoft et al., 2010)
in an attempt to summon adequate clinical management to address the
problem in a rapidly expanding, ageing population. Adult skeletal muscle
regeneration is largely dependent on a resident stem cell population of
satellite cells (Mauro, 1961). Satellite cells are mononuclear cells that are
peripherally located underneath the basal lamina of mature myofibres
and can be activated upon relevant cues to proliferate. A subset of these
satellite cells return to quiescence to renew the pool for future regenera-
tive bouts, while the remainder progress into myoblasts, which migrate
to the reparative site and differentiate ⁄ fuse to become incorporated into
multinucleated myotubes, repairing the existing skeletal muscle fibre. This
is fundamental in the way in which skeletal muscle displays its astounding
plasticity during development, exercise, stretch and mechanical loading
with an increase in size (hypertrophy). However, with such sensitive regu-
lation, severe loss (atrophy) commonly occurs with ageing, disuse and dis-
ease that is characterized globally by changes in protein synthesis and
protein degradation that lead to muscle mass reductions. Given the key
roles that these cells play, it is imperative that they are critically investi-
gated to provide better understanding of the processes underlying skele-
tal muscle ageing. This is particularly relevant, given recent findings,
suggesting that human muscle-derived cells show impaired differentia-
tion and thus reduced regenerative potential vs. the cells of younger
donors (Pietrangelo et al., 2009; Beccafico et al., 2010), with an associ-
ated loss of myogenicity (Hidestrand et al., 2008) yet without change in
telomere length or telomerase activity (O’Connor et al., 2009).
Myoblasts that have undergone multiple replicative divisions (Sharples
et al., 2010, 2011) or which display features of senescence in vitro (Bigot
et al., 2008) have been used to investigate ageing in monolayer cultures.
Although these eloquent monolayer studies have modelled and thus
revealed some important cellular and molecular mechanisms involved in
the serial rounds of divisions with age and the regulation of senescence,
owing to their single cell–layered nature, these models do not portray
three-dimensional (3D) in vivo SkM structure [discussed in Sharples &
Stewart (2011)]. Using a 3D bioengineered model of SkM that incorpo-
rates a representative extracellular matrix (type I collagen) is under tension
and displays representative morphological, histological and transcript
expression of mature skeletal muscle may more accurately characterize
the SkM niche (Cheema et al., 2003; Mudera et al., 2010; Smith et al.,
2011). As a result, not only will these models act as a potential surrogate
and reduce the need of often frail elderly in vivo human trials and
biopsies, they will allow greater experimental manipulation, including
gene knock-down, transfection, pharmacological interventions and the
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ability to be ‘exercised’ in vitro (Player et al., 2011). Further, a greater
understanding of the cellular and molecular regulators of SkM during
ageing will be available.
Therefore, in the present study, myoblasts were studied that had
undergone multiple population doublings and thus potentially recapitu-
late the rounds of population expansion and self-renewal that occur
in vivo across the lifespan (Sharples et al., 2011). These myoblasts have
previously been shown to display reduced regeneration in monolayer
cultures, characterized by reduced morphological and biochemical differ-
entiation, reduced cell cycle exit and associated decreases in IGF-I, myoD,
myogenin mRNA and Akt signalling with increases in IGFBP5 mRNA and
JNK signalling (Sharples et al., 2011). Interestingly, similar morphology,
transcript and signalling processes are also observed in cells isolated from
elderly human muscle (Bigot et al., 2008; Pietrangelo et al., 2009;
Beccafico et al., 2010) and in whole tissue biopsies (Cuthbertson et al.,
2005; Leger et al., 2008). Thus, by transferring these cells into 3D
bioengineered type I collagen constructs this can potentially recapitulate,
in-vitro, a model that represents aged skeletal muscle and displays a
physiologically more relevant tissue, similar to that found in-vivo, allowing
future manipulations in terms of therapeutic interventions in combating
skeletal muscle wasting with age. Indeed, it is here reported that 3D bio-
engineered constructs incorporating myoblasts that have undergone mul-
tiple population doublings (MPD) have aligned but smaller and thinner
myotube formation (atrophied) vs. aligned but thicker and larger myotu-
bes (hypertrophied) in parental controls, shown by reductions in myotube
size and diameter. These MPD constructs are characterized by reduced
peak force development over 24 h after cell seeding, reduced transcript
expression of remodelling matrix metalloproteinases (MMP2 and MMP9),
with reduced differentiation ⁄ hypertrophic potential shown by reduced
IGF-I, IGF-IR, IGF-IEa, MGF and increased IGFBP2 mRNA, and finally
increased expression of catabolic transcripts (myostatin and TNF-a) vs.
parental cellular constructs. Thus, providing an exciting future in vitro 3D
bioengineered model that is more representative of an ageing ⁄ atrophied
muscle in vivo in order to investigate the cellular and molecular mecha-
nisms for deterioration of regeneration observed in skeletal muscle and
provide a future test bed for pharmacological, gene and exercise thera-
pies. Finally, this model could potentially be used for muscle-wasting dis-
orders using diseased cells or for example in cachexia with the addition of
influential systemic factors such as growth factors and cytokines such as
tumour necrosis factor-alpha (TNF-a).
Materials and methods
Cell culture
C2C12 murine skeletal myoblasts (Yaffe & Saxel, 1977; Blau et al., 1985)
(purchased from ATCC, Rockville, MD, USA) were grown in T75 ⁄ T175
flasks in a humidified 5% CO2 atmosphere at 37 C in growth medium
GM, composed of: Dulbecco’s modified Eagle’s medium ⁄DMEM (Sigma,
Poole, UK) plus 20% FBS (PAA Laboratories, Somerset, UK), and 1% peni-
cillin–streptomycin solution (Invitrogen, Paisley, UK), until 80% conflu-
ence was attained. Prior to collagen ⁄myoblast construct preparations,
cells were washed twice in PBS, trypsinized and counted (1:1 trypan blue).
12 · 106 total cells were then pelleted via centrifugation at 2000 g for
5 min for use in specific experimentation.
Multiple population doublings of C2C12 cells
Population doublings were carried out as in (Sharples et al., 2011).
Briefly, original stock C2C12 mouse skeletal muscle cells were seeded at
1 · 106 cells in T75 flasks in 15 mL of GM and incubated for 48 h until
80% confluent. Cells were trypsinized and seeded onto new T75s at
1 · 106 for 48 h or at 5 · 105 for 72 h, cell number and doubling time
being recorded throughout. This cycle was repeated 20 times over
49 days, creating a stock of cells that had undergone 58 population dou-
blings (multiple population doublings ⁄MPD) (Sharples et al., 2011) com-
pared with the original stock that were retained in liquid nitrogen and
had undergone no subsequent doublings (CON) relative to the MPD cells.
These cells were used as the controls in all experiments reported here,
that is, the same ‘parental cells’ that had produced their progeny were
used as control cells. There was no observable cell death between cell
expansions (determined by trypan blue).
Collagen ⁄myoblast construct preparation
Constructs were prepared as previously published (Cheema et al., 2003;
Mudera et al., 2010; Smith et al., 2011). Supernatant was removed from
the centrifuged 12 · 106 cell pellet and re-suspended in a volume of
0.1 mL GM. 2.6 mL of rat tail collagen type I (2.16 g mL)1; First Link, Bir-
mingham, UK) was added to 0.3 mL of 10· Eagle’s Minimum Essential
Medium (EMEM) (Gibco, Paisley, UK). The solution was neutralized in a
drop-wise manner using 5 and 1 M sodium hydroxide. Following neutral-
ization, 12 · 106 cells were added to the collagen ⁄ EMEM solution. This
collagen ⁄ cell solution was set in standard dimension chamber slides
(45 · 20 · 10 mm) between two pre-sterilized polyethylene mesh flota-
tion bars, attached to the chambers via stainless steel frames (A-Frames;
Fig. 1A). These constructs polymerized for 30 min in a humidified 5%
CO2 atmosphere at 37 C before being detached using a 21-G needle.
Five millilitres of GM was added to the chambers with the flotation bars
facilitating resistance against the chamber slide to generate the uniaxial
tension (Fig. 1A). After cell attachment (24 h), the myoblast ⁄ collagen
constructs were washed ·2 PBS followed by 5 mL low-serum differentia-
tion media (DM), composed of DMEM plus 2% horse serum, 1% penicil-
lin–streptomycin solution. C2C12 myoblasts undergo spontaneous
differentiation into myotubes on serum withdrawal, and do not require
growth factor addition (Yaffe & Saxel, 1977; Blau et al., 1985). Con-
structs were fixed for imunno-histological analysis and lysed for transcript
expression at 3, 7 and 14 days time points. Constructs were attached to a
Culture Force Monitor (CFM) to measure force and rate of force develop-
ment every minute for 24 h following initial seeding.
Culture Force Monitor measurements
The CFM is a custom built device that measures real-time force contrac-
tion of 3D cellular constructs (Eastwood et al., 1994; Mudera et al.,
2010). This measurement was used to assess the amount of force devel-
oped by the cells attaching to the matrix over the first 24 h after seeding,
as previously described (Cheema et al., 2003; Mudera et al., 2010), for
both the MPD and CON cells seeded into type I collagen, as detailed
previously. Amendments to the originally published system have been
developed as part of this project (referred to as CFMmk2). The measuring
beam of the CFM mk2 was manufactured from 0.15-mm Copper-Beryl-
lium sheet (Goodfellow Metals Ltd, Cambridge, UK) cut into strips
(100 · 10 mm). Transducer class strain gauges (Wellyn Strain Measure-
ment, Basingstoke, Hants, UK) were attached to the Copper-Beryllium
beams in a full bridge electrical network at 20 mm from one end. A hook
was soldered onto the end of the measuring beam connected to the con-
structs through the stainless steel wire ‘A frames’ (Fig. 1A). The force
transducer was attached through a wired mechanism to a Model P3
Strain Indicator and Recorder (Vishay, Basingstoke, UK) connected to a
3D bioengineered model of aged skeletal muscle, A. P. Sharples et al.
ª 2012 The Authors
Aging Cell ª 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
987
computer via USB. This unit acted as a bridge amplifier, static strain indi-
cator and digital data logger. Micro-strain (le) and time data were col-
lected at a rate of 1 Hz (one reading per second) for all measurements.
Before experimentation the force transducers were calibrated to provide
an equation to convert the micro-strain (le) reading to micro-Newton’s
(lN). Force transducers were left in a humidified 5% CO2 atmosphere at
37 C for a period of 24 h and calibrated against known masses of 0.03,
0.05, 0.2, 0.3, 0.5 g, corresponding to 294, 491, 1962, 2943, 4905 lN
(where: weight (g) was converted to Kg and multiplied by 9.81 m s)1 to
calculate Newtons (N); the resultant was divided by 1000 to calculate
lN). The micro strain (le) was recorded for each weight for 5 min and
plotted against lN. The resultant linear equation was used to convert le
to lN generated by the myoblast ⁄ collagen constructs. The le was
recorded every minute for a period of 24 h after seeding the myoblasts in
the collagen gels.
Immunohistology and microscopy
Whole mounted constructs were washed ·2 with PBS and fixed (3.7%
paraformaldehyde), permeabilized, blocked (0.2% Triton, 2% Goat
Serum, diluted in TBS solution) and stained using mouse monoclonal anti-
desmin antibody (diluted 1 in 200; Sigma). Secondary antibody, goat
anti-rabbit IgG TRITC (diluted 1:200; Sigma) was added to enable fluores-
cent detection. SYTOX nuclear stain (Molecular Probes, Paisley, UK)
diluted 1 in 2000 was used to counterstain nuclei. The sections were visu-
alized using a Zeiss LSM 510 fluorescent microscope (40·) with manufac-
turer’s software. TRITC was excited at 485 nm and emitted at 520 nm
and appears red in images presented. SYTOX nuclear stain was excited
at 504 nm and emitted at 523 nm and appears green. Images for all con-
ditions were taken and analysed for morphological analyses of myotube
area (lm2) and diameter (lm) using IMAGE J (Java) software (National Insti-
tute of Health, Bethesda, MD, USA).
RNA extraction and analysis
Constructs were immersed and homogenized in 0.5 mL TRIzol. RNA was
extracted according to manufacturer’s instructions. RNA concentration
and purity were assessed by UV spectroscopy at ODs of 260 and 280 nm
using a Nanodrop 3000 (Fisher, Rosklide, Denmark). 70 ng RNA was used
for each PCR reaction.
Primer design
Primer sequences (Table 1) were identified using Gene (NCBI, http://
www.ncbi.nlm.nih.gov/gene) and designed using both web-based Oligo-
Perfect Designer (Invitrogen, Carlsbad, CA, USA) and Primer-BLAST
(NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Sequence
homology searches ensured specificity. The primers were ideally designed
(A) (B)
(C)
(D) (E)
Fig. 1 (A,B) Depicts the control (CON; A)
and multiple population doubling (MPD; B)
collagen constructs that have been
polymerised between the two flotation bars
that are in-turn attached to the chamber
slide via metal ‘a-frames.’ There was
reduced bowing (indicated by ﬁ ) and
larger construct diameters (indicated byM)
in MPD constructs vs. CON. (C) Depicts
statistically significant reductions in
construct diameter over the time course in
CON cells but not MPD (#P = 0.001; C) and
significantly impaired bowing in the MPD
cells indicated by larger construct diameters
in MPD cells at 3, 7 and 14 days
(*P = 0.001; C). (D) Depicts the mean force
traces of CON (black) vs. MPD (dark grey)
after initial seeding into collagen matrices
up to 24 h. (E) Depicts the statistically
significant *difference in peak force that
was impaired in MPD cells vs. CON.
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to yield products spanning exon-exon boundaries to prevent any
amplification of gDNA. Three or more GC bases in the last five bases at
the 3¢ end of the primer were avoided. Secondary structure interactions
(hairpins, self-dimer and cross dimer) within the primer were avoided. All
primers were between 18 and 23 bp, and amplified a product of
between 76 and 350 bp. GC content was between 38.1% and 55.6%
(Table 1). Primers were purchased from Sigma (Suffolk, UK) without the
requirement of further purification.
Reverse transcriptase quantitative Real-Time Polymerase
Chain Reaction (rt-qRT-PCR)
rt-qRT-PCR amplifications were performed using QuantiFast SYBR
Green RT-PCR one step kit on a Rotogene 3000Q (Qiagen, Crawley, UK)
supported by rotogene software (Hercules, CA, USA). rt-qRT-PCR was
performed as follows: Hold 50 C for 10 min (reverse transcription ⁄ cDNA
synthesis), 95 C for 5 min (transcriptase inactivation and initial denatur-
ation step) and PCR Steps of 40 cycles; 95 C for 10 s (denaturation),
60 C for 30 s (annealing and extension). Upon completion, dissocia-
tion ⁄melting curve analyses were performed to reveal and exclude non-
specific amplification or primer-dimer issues. The relative gene expression
levels were calculated using the comparative Ct (
DDCt) equation otherwise
known as the Livak method (Schmittgen & Livak, 2008), where the
relative expression is calculated as 2DDCt and where Ct represents the
threshold cycle. Following screening of GAPDH, RPII-a and RPII-b; RPII-b
showed the most stable Ct values and was selected as the reference gene
in all RT-PCR assays. A pooled Ct value (17.4 ± 1.02) for the housekeep-
ing gene, RPII-b, was derived from all rt-qRT-PCR runs. To compare MPD
C2C12 cells with CON C2C12, proliferating monolayer CON cells that had
been grown in GM for 24 h and then transferred to DM for 30 min (0 h
time point) were routinely used as the calibrator condition in the Ct
(DDCt) equation. Rt-qRT-PCR data presented in results ⁄ figure are there-
fore relative gene expression levels determined by the DDCt equation.
Statistical analyses
Statistical analyses were determined using MINITAB version 16.0 (Minitab
Inc., PA, USA and LEAD Technologies, Inc., NC, USA). Results are pre-
sented as mean ± standard deviation (SD). Statistical significance for
interactions between cell type (CON and MPD) and time (3, 7 and
14 days) were determined using (2 · 3) mixed two-way Factorial ANOVA.
Results for factorial ANOVA’s Post hoc analyses (with Bonferroni correction)
were conducted where main effects for cell type or time occurred, with-
out a significant interaction between time and cell type. If there were sig-
nificant interactions present, independent t-tests were conducted to
confirm statistical significance between variable of interest e.g. between
cell types, and paired-sample t-tests undertaken for variable of interest
within cell type and time. For all statistical analyses, significance was
accepted at P £ 0.05.
Results
Maintained construct diameter and lower force in multiple
population doubling (MPD) bioengineered constructs vs.
controls
Myoblasts, once seeded within the constructs, to mature, must first
attach to the matrix and remodel this matrix (also see MMP expression
below) to differentiate and fuse into myotubes at later time points (Mu-
dera et al., 2010). This attachment, then subsequent fusion creates a
characteristic bowing morphology in the constructs (Fig. 1A; indicated
by ﬁ ). The changes in bowing can be grossly measured via construct
diameter (mm; indicated as M in Fig. 1A). Morphologically, MPD cells
maintained construct diameter at all time points (Fig. 1B) vs. CON cells
(Fig. 1A) where construct diameter reduced across the time course
(3 days; 13.22 ± 1.64 mm, MPD vs. 10.8 ± 1.98 mm, CON, P = 0.079,
7 days; 12.9 ± 0.49 mm, MPD vs. 8.9 ± 0.58 mm, CON, P £ 0.001,
14 days; 13.43 ± 0.13 mm, MPD vs. 8.24 ± 0.27 mm, CON, P £ 0.001;
Fig. 1C). This was suggestive that the CON cells were attaching to the
matrix whereas MPD cells may have displayed an inability to attach to the
matrix suggested previously (Cheema et al., 2003; Mudera et al., 2010).
Indeed, this also resulted in a smaller average force trace (Fig. 1D) and
reduced peak force in MPD cells vs. CON over the initial 24 h (Fig. 1E)
after seeding within the collagen matrices (CON, 327.38 ± 98.87 vs.
MPD, 200.79 ± 20 lN; P = 0.048, Figs 1D,E).
MPD cells have reduced matrix remodelling potential vs.
control CON cells
In addition to reduced force generating potential and bowing, indicative
of reduced cell attachment (Cheema et al., 2003; Mudera et al., 2010),
MPD cells in type I collagen matrices also show average reductions in
expression of matrix metalloproteinase 2 at both 3 and 7 days (3 days;
7.29 ± 1.74, MPD vs. 12.32 ± 3.72, CON, P = 0.071, 7 days; 15.08 ±
2.74, MPD vs. 27.79 ± 11.49, CON, P = NS; Fig. 2A), by 14 days MMP2
transcript expression was similar betweenMPD and CON (Fig. 2A). Signif-
icant and similar trends were observed in MMP9 expression at 3 days
(Fig. 2B), where MPD cells had impaired expression vs. CON (3 days;
0.98 ± 0.14, MPD vs. 1.68 ± 0.32, CON, P = 0.016; Fig. 2B). Although
expression remained impaired in MPD vs. CON cells at 7 and 14 days, the
Table 1 Real time qPCR primer sequences
Target gene Primer Sequence (5¢–3¢)
Ref. seq.
number
Amplicon
length (bp)
IGF-I F: GCTTGCTCACCTTTACCAGC NM_010512 280
R: TTGGGCATGTCAGTGTGG
IGF-IR F: TGCGGTGTCCAATAACTAC NM_010513.2 110
R: TGTTGATGGTGGTCTTCTC
IGF-IEa F: GCTTGCTCACCTTTACCAGC NM_010512 300
R: AATGTACTTCCTTCTGGGTCT
IGF-IEb ⁄MGF
in mouse
F: GCTTGCTCACCTTTACCAGC NM_010512 353
R: AAATGTACTTCCTTTCCTCTC
IGFBP5 F: GAAGAGGTGGTGACAGAG NM_010518.2 104
R: TGACAACAAGATCGGGAA
IGFBP2 F: AGTGCCATCTCTTCTACAA NM_008342.3 197
R: GCTCAGTGTTGGTCTCTT
Myogenin F: CCAACTGAGATTGTCTGTC NM_031189.2 173
R: GGTGTTAGCCTTATGTGAAT
Myostatin F: TACTCCAGAATAGAAGCCATAA NM_010834.2 194
R: GTAGCGTGATAATCGTCATC
TNF-a F: TCAACAACTACTCAGAAACAC NM_013693.2 130
R: AGAACTCAGGAATGGACAT
TNFRI F: CTGATCTCTATCTGCCTCTG NM_011609.4 101
R: CGCTCGTGAATGAAGTAAG
MMP2 F: GACAAGTTCTGGAGATAC NM_008610.2 155
R: TAATAAGCACCCTTGAAG
MMP9 F: CTGGCAGAGGCATACTTG NM_013599.2 76
R: GCCGTAGAGACTGCTTCT
RP-IIB F:GGTCAGAAGGGAACTTGTGGTAT NM_153798.2 197
R:GCATCATTAAATGGAGTAGCGTC
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differences were non-significant (Fig. 2B). Overall, trends suggest early
mean reductions in MMP2 and significant early decreases in MMP9 may
underpin the impaired ability to degrade the matrix to initiate both cell
matrix (indicated via reduced bowing and inability to contract the matrix
in MPD cells; described above) and cell-cell interactions; a perquisite for
myoblast differentiation ⁄ fusion into myotubes, a phenotype that is also
impaired in the MPD cells (Sharples et al., 2011). Immuno-staining for
desmin in the constructs illustrates impaired myoblast fusion in MPD con-
structs, manifested by smaller, thinner myotubes vs. extensive and larger
myotubes in CON constructs (Fig. 3A vs. Fig. 3B).
Reduced myotube size and diameter is observed in MPD
constructs vs. control
Both constructs were aligned morphologically like skeletal muscle in vivo
(Fig. 3C,D, and; after quantification of myotube size and area at 14 days
MPD constructs showed significantly smaller and thinner myotubes vs.
CON constructs (size lm2: 2696 ± 334 in MPD vs. 4976 ± 928 in CON;
P = 0.05, Fig. 3C; and diameter, lm: 15.38 ± 1.53 in MPD vs.
30.16 ± 4.79 in CON; P = 0.036, Fig. 3D). Overall indicating an
atrophied skeletal muscle constructs using MPD cells vs. hypertrophied
constructs (CON).
Reduced differentiation ⁄hypertrophy in 3D bioengineered
myoblast ⁄ collagen constructs in MPD cells vs. CON is
underpinned by reductions in transcript expression of
myogenic regulatory factor; myogenin, and insulin-like-
growth factor family members: IGF-I, IGF-IR, IGF-IEa and
MGF
Decreased transcript expression of the differentiation regulator, myoge-
nin further substantiated the morphological analyses. Expression was
(A) (B)
Fig. 2 Average reductions in expression of
matrix metalloproteinase 2 (MMP2) mRNA
specifically at early time points 3 and 7 days
was non-significant (A), however, MMP9
was significantly lower in MPD myoblasts at
3 days indicated by * (B). Data is taken from
three experiments in duplicate.
(A) (B)
(C) (D)
Fig. 3 (A) CON vs. (B) MPD collagen
constructs differentiated over a 14 day
period both demonstrating aligned
myotube structures. CON constructs show
larger and thicker myotube structures
(hypertrophied) vs. MPD constructs that
have smaller and thinner constructs
(atrophied). (C) Myotube area and (D)
myotube diameter morphological analyses
also suggested that there was a statistically
significant reduction in myotube area
(P = 0.05) and diameter (P = 0.038) in MPD
constructs. Confirming the atrophied
phenotypes in MPD constructs vs. control
constructs.
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reduced at all times points, approaching significance at 3 days and
reaching significance at 7 days (3 days; 2.5 ± 0.39, MPD vs. 6.19 ± 2.94,
CON, P = 0.089, 7 days; 3.49 ± 0.54, MPD vs. 7.04 ± 1.76 mm, CON,
P £ 0.031, 14 days; 4.89 ± 1.3, MPD vs. 6.5 ± 1.93, CON, P = NS;
Fig. 4A). Expression of IGF-I and its receptor, IGF-IR, were significantly
decreased at 3 days in MPD vs. CON cells (IGF-I 3 days; 0.44 ± 0.21,
MPD vs. 1.99 ± 0.6, CON, P = 0.016, Fig. 4B, IGF-IR 3 days;
0.46 ± 0.05, MPD vs. 0.82 ± 0.03, CON, P = 0.001; Fig. 4C), however,
despite reductions continuing over the 14 days period, significance was
not attained for IGF-I. IGF-IR was also not significantly different between
MPD and CON at 7 days (Fig. 4C). Interestingly, however, IGF-IR expres-
sion was significantly greater at 14 days in MPD constructs vs. CON
(0.69 ± 0.04 MPD vs. 0.56 ± 0.02, CON, P = 0.003; Fig. 4C), perhaps
indicating a delayed temporal response. IGF-IEa was decreased early in
MPD constructs relative to CON, as was MGF (IGF-IEa 3 days;
0.57 ± 0.31, MPD vs. 1.82 ± 0.59, CON, P = 0.02, Fig. 4D, MGF 3 days;
0.41 ± 0.28, MPD vs. 0.89 ± 0.13, CON, P = 0.036; Fig. 4E). MGF con-
structs at 7 days had reduced levels at this time point, that almost
achieved significance (7 days; 0.43 ± 0.29, MPD vs. 0.87 ± 0.12, CON,
P = 0.064; Fig. 4E). At 14 days there were no significant differences
observed betweenMPD constructs for IGF-IEa or MGF (Fig. 4D,E).
IGFBP2 remains high across the 14 day time course in MPD
constructs vs. a high to low temporal expression in CON, in
the face of unaltered IGFBP5
It has previously been shown that for adequate differentiation of myo-
blasts to occur, IGFBP2 expression must decrease across the time course
(Ernst et al., 1992; Sharples et al., 2010). Therefore, the high levels
observed across the time course in MPD constructs vs. the high to low
temporal expression in CON constructs may contribute to the reduced
differentiation potential observed. At 3 days levels are high and compara-
ble in both MPD and CON constructs (3 days; 0.12 ± 0.07, MPD vs.
0.07 ± 0.04, CON, P = NS; Fig. 4F), however, maintained high levels
were observed in MPD cell at 7 (significant) and 14 days (approaching
significance) vs. a reduction in CON cells across the time course (7 days;
(A) (B)
(C) (D)
(E) (F)
Fig. 4 (A) Myogenin mRNA is reduced at
all times points, reaching significance at
7 days. (B) Insulinlike-growth factor-I (IGF-I)
and its receptor, IGF-IR (C) are significantly
decreased at 3 days in MPD constructs.
IGF-IR expression was significantly greater at
14 days in MPD constructs vs. CON
(indicated by *, C), perhaps indicating a
delayed temporal response. (D) IGF-IEa was
decreased early (3 days) in MPD constructs
relative to CON, as was MGF (E). MGF
approached significance with reduced
expression at 7 days (E). (F) IGFBP2 levels are
high in both MPD and CON constructs
shown by similar expression, however MPD
cells maintained high levels at 7 (significant)
and 14 days (approaching significance) vs. a
reduction in CON cells across the time
course. Data is taken from three
experiments in duplicate.
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0.11 ± 0.04, MPD vs. 0.03 ± 0.01, CON, P = 0.02, 14 days;
0.14 ± 0.07, MPD vs. 0.03 ± 0.03, CON, P = 0.074; Fig. 4F). Despite
expression levels of IGFBP5 being increased in MPD vs. CON constructs at
7 and 14 days, significance was not attained (data not shown).
Increased myostatin and TNF-a but not TNFRI further
underpin differences between MPD and CON constructs
Myostatin expression is not significantly different between CON and MPD
constructs at early time points (3 days; 107.97 ± 39.69, MPD vs.
283.14 ± 220.98, CON, P = NS; Fig. 5A) and late time points (14 days;
162 ± 56.86, MPD vs. 142.03 ± 85.46, CON, P = NS; Fig. 5A), however,
is significantly increased in MPD constructs vs. CON at 7 days
(128.33 ± 16.38, MPD vs. 80.92 ± 19.83, CON, P = 0.014, Fig. 5A).
TNF-a was also increased in MPD cells at the 7 days time point vs. CON
constructs (29.16 ± 8.94, MPD vs. 13.07 ± 4.02, CON, P = 0.014;
Fig. 5B), again without (like myostatin) significant differences at early and
late time points (3 days; 24.15 ± 15.68, MPD vs. 41.9 ± 41.45, CON,
P = NS, 14 days; 41.8 ± 29.57, MPD vs. 27.8 ± 4.2, CON, P = NS;
Fig. 5B). Despite a significant difference in TNF-a, its associated receptor
TNFRI was unchanged at any time point (data not shown).
Discussion
The present study utilized a current murine myoblast replicative ageing
model (Sharples et al., 2011), a concept that has been used to investigate
senescence in human myoblasts (Mouly et al., 2005; Bigot et al., 2008),
to develop novel three-dimensional (3D) bioengineered skeletal muscle
constructs that displayed reduced differentiation and atrophied morphol-
ogy vs. their parental, non-divided controls. Firstly, this model provided a
more physiologically relevant tissue with respect to in vivo muscle fibres,
as can be seen by the aligned myotubes (Fig. 3A,B) vs. that of monolayer
cultures that display swirling myotubes owing to lack of unilateral
tension. Secondly, using this model, myotubes are smaller ⁄ thinner in the
MPD constructs vs. parental controls; a phenotype of ageing skeletal
muscle fibres measured histologically (Edstrom & Ulfhake, 2005), in cells
that have been isolated and induced to differentiate (Pietrangelo et al.,
2009; Beccafico et al., 2010) and finally at the in vivo level indicated via
reductions in physiological cross sectional area (Morse et al., 2005a).
Indeed, it should be noted that type I collagen used to generate the 3D
dimensional constructs in the present study, is only one extracellular
matrix molecule that is not necessarily representative of complex in-situ
muscle ECM. However, perimysial collagen is predominantly type I,
whereas type III collagen appears to be more evenly distributed between
endomysium and epimysium (Gillies & Lieber, 2011). Future work may
wish to incorporate type III collagen into these constructs to further mimic
the cell niche. However, the present model certainly supersedes mono-
layer models of ageing myoblasts with respect to morphology that is rep-
resentative of skeletal muscle in-vivo.
In addition to the smaller, thinner myotubes observed in MPD con-
structs they also displayed significant decreases in myogenin mRNA, a
muscle specific transcription factor that is directly involved in fusion by
promoting the expression of key cytoskeletal transcripts and proteins
such as; myosin heavy chains, troponin, creatine kinase, titin and desmin
in order for regeneration to occur [reviewed in Berkes & Tapscott (2005)].
Indeed, a reduction in myogenin and thus differentiation has been previ-
ously observed in replicatively aged human and mouse myoblasts (Bigot
et al., 2008; Sharples et al., 2011). Despite this, a recent investigation
suggested that myoD and myogenin levels were increased with age, and
proposed as mechanism ⁄ drive in an attempt to attempt to compensate
for the reduction in muscle mass with age (Edstrom & Ulfhake, 2005).
However, the changes in myoD ⁄myogenin in these in vivo studies should
be viewed with caution, since mRNA isolated fromwhole muscle contains
a mixture of mature fibres and satellite cells ⁄myoblasts. MyoD ⁄myogenin
are still expressed in mature fibres to maintain transcriptional control and
cytoskeletal integrity (Ferri et al., 2009) as well as highly expressed in
regenerating myoblasts. Levels could therefore be under ⁄ overestimated
if regenerative processes are altered in ageing. It is therefore possible that
the mature fibres are producing myoD ⁄myogenin to a greater extent
than the activated satellite cells in elderly individuals, with investigations
suggesting that muscle cells isolated from elderly populations show
reduced myoD ⁄myogenin once isolated in culture (Bigot et al., 2008).
This indeed seems to be the case in the present study, where myogenin is
reduced significantly in MPD vs. CON at 3 and 7 days while the constructs
are continuing to differentiate, whereas at 14 days when the constructs
are differentiated, myogenin is not significantly different to CON
constructs.
Insulin-like growth factors (IGFs) influence hypertrophy of primary and
cell line skeketal muscle cultures; enhancing proliferation, differentiation
(Florini et al., 1996), survival (Stewart & Rotwein, 1996), satellite cell
recruitment (Jacquemin et al., 2004) and myofibrillar protein accretion
(Quinn et al., 2007). Local IGF-I production by skeletal muscle is also
important in hypertrophy, where liver deficient IGF-I mice showed similar
strength gains vs. controls following overload via increases in IGF-I recep-
tor tyrosine phosphorylation. Therefore, as IGF-I has been shown to be
reduced in both the circulation (Benbassat et al., 1997) and locally by the
muscle in elderly individuals (Welle et al., 2002; Leger et al., 2008) and
has the ability to restore skeletal muscle mass in old mice (Barton-Davis
et al., 1998), the reduction in IGF-I by the MPD constructs seems to mimic
this reduced response. This reduction in IGF-I certainly seems to underpin
(A) (B)
Fig. 5 (A,B) Myostatin (A) and TNF-a
(B) mRNA are significantly increased in MPD
constructs vs. CON at 7 days. Data is taken
from three experiments in duplicate.
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the inability of the cells to differentiate, as described previously in mono-
layer cultures with corresponding decreases in downstream Akt (Sharples
et al., 2011). It is however worth pointing out that at 7 and 14 days in
the present study, although there was mean reductions in IGF-I, this was
not significant. This would oppose the in vivo findings of reduced mRNA
levels in elderly muscle tissue taken from biopsies. Recent evidence has
however, begun to question the role of IGF-I in hypertrophy of mature
skeletal muscle, especially following damage, with the inhibition of IGF-I
signalling (mice overexpressing a dominant negative form of IGF-IR or
‘MKR’ mice), eliciting similar hypertrophic responses, following synergistic
ablation of the plantaris muscle compared to wild-type mice (Spangen-
burg et al., 2008); suggesting IGF is not important in hypertrophy follow-
ing overload. Recently, the mechanisms for this have become clear where
mechanical stimulation can directly activate signals downstream yet inde-
pendently of IGF-I ⁄Akt signalling (Miyazaki et al., 2011), with mamma-
lian target of rapamycin mTOR a key regulator of this hypertrophic
response (Miyazaki et al., 2011). The evidence for the role of IGF-I in myo-
blast differentiation and thus regeneration for homoeostasis rather than
after overload, however, is fairly robust (Coolican et al., 1997; Al-Shanti
& Stewart, 2008), and indeed, even when using the MKR mouse model,
it was shown that IGF-I is fundamental in myoblast fusion, with primary
MKR myoblasts showing impaired differentiation, vs. wild-type controls,
following damage (Heron-Milhavet et al., 2010). Therefore, it is feasible
that the reduction of IGF-I, as observed in the present MPD model, may
account for the overall reductions in transcript found in muscle biopsies
taken from older individuals, rather than the basal production from
mature fibres. Overall, implicating the mitotically capable satellite cell fur-
ther in its effect on the degenerative phenotype observed in skeletal mus-
cle with respect to IGF-I production.
It has also been established that a significant relationship between
lower resting levels of MGF (an isoform of IGF-I; IGF-IEc in humans ⁄ IGF-
IEb in mice) and lower whole muscle cross sectional area in elderly people
(Hameed et al., 2004). Furthermore, elderly individuals have blunted
responses to mechanical stimulation with respect to these isoforms (Owi-
no et al., 2001). Indeed, both of these isoforms were reduced in the pres-
ent model. In-vitro, it has been demonstrated knock-down of IGF-IEa in
C2C12 cells causes differentiation and subsequent hypertrophy of myotu-
bes but the inhibition of proliferation, whereas MGF has the opposite
effect (activation of proliferation ⁄ inhibition of differentiation) (Yang &
Goldspink, 2002). It is therefore not surprising that following resistance
exercise, MGF is expressed temporally before IGF-IEa as this would mean
proliferation predominates initially after damage followed by differentia-
tion for repair (Owino et al., 2001; Yang & Goldspink, 2002; Hameed
et al., 2003). Owino et al. (2001) showed that overload increased MGF
expression in both young and old individuals; however, the expression
reached a plateau at 24 h in elderly vs. a continued increase over 5 days
in young. As these transcripts are reduced in the current MPD model this
results in a similar response to base line ⁄ resting levels in vivo human stud-
ies, however, MGF is significantly lower in MPD cells at both 3 and 7 days,
suggesting that the cells may reduce their proliferation and enhance dif-
ferentiation vs. CON cells that have higher levels (Yang & Goldspink,
2002). However, this was not observed in monolayer, where MPD cells
continue to cycle and not exit the cell cycle in G1 to differentiate (Sharples
et al., 2011) and also not observed phenotypically in the current 3D
model. It is worth noting that lower MGF levels in MPD cells vs. CON is
also in the face of reduced IGF-IEa that would impair differentiation. Fur-
ther, it is noticeable that cells in these 3D construct do not differentiate as
quickly (between 7 and 14 days – Fig. 3A) in both CON and MPD cells as
in monolayer where myotubes begin forming after 48 h following serum
withdrawal in monolayer (Sharples et al., 2010, 2011). Therefore,
together with reduced IGF-IEa levels the change in niche may account for
the discrepancy in MGF levels across the time course of differentiation.
This model warrants further investigation with respect to MGF and IGF-
IEa responses following mechanical stimulation, and could provide an
interesting model to elucidate delayed temporal responses to key ana-
bolic mechanisms following exercise, as this model can be mechanically
stretched in vitro (Cheema et al., 2005; Player et al., 2011).
IGF binding proteins (IGFBPs) modulate and mediate IGF-I action. Spe-
cifically, IGFBP2 binds IGF-I with high affinity and can manipulate its bind-
ing to the IGF-I receptor. It has previously been shown that IGFBP2 at high
levels correlates with proliferation and reduces as cells differentiate (Ernst
et al., 1992; Sharples et al., 2010). In the present study the MPD con-
structs have high expression at all-time points suggesting a mechanism
for the reduced differentiation observed, where the CON group have a
high to low expression across the investigated time course, which has
previously been linked with enhanced differentiation (Sharples et al.,
2010). The mechanism by which IGFBP2 achieves this may be due to its
direct role in binding to IGF-I and inhibiting the subsequent binding to the
IGF-IR, or owing to an indirect mechanism whereby IGFBP2 has been
shown to bind to the a5b1 integrin receptor via the integrin arginine-gly-
cine-aspartate (RGD) motif in its C terminal domain (Binkert et al., 1989).
This interaction, potentially alters Akt phosphorylation, downstream of
the IGF-I receptor, following integrin-induced FAK phosphorylation and
alteration in the phosphatase and tensin homologue, PTEN (Wheatcroft
& Kearney, 2009). However, this mechanism is yet to be fully determined
in skeletal muscle per se, and thus, no evidence for a role in ageing mus-
cle is currently available. This therefore requires further investigation,
especially as high expression across the time course is evident in C2C12
MPD constructs with reduced differentiation phenotypes. Also as paren-
tal ‘older’ C2 cells in monolayer display increased IGFBP2 expression and
reduced regeneration vs. their ‘younger’ daughter C2C12 cells that display
decreased IGFBP2 expression over time (Sharples et al., 2010).
Tumour necrosis factor-alpha (TNF-a) is a pleiotropic cytokine impli-
cated as a mediator of muscle wasting in many disease states and in age-
ing (Leger et al., 2008). TNF-a is increased significantly at 7 days in the
MPD constructs vs. CON, at a time, when CON cells seem to be fusing
and MPD are perhaps still proliferating. Interestingly, it has previously
been shown that TNF-a is required for early satellite cell activation follow-
ing damage and inflammation. However, TNF-a if chronically elevated
can lead to muscle wasting (Stewart et al., 2004), suggesting that in MPD
constructs, the elevation in TNF may sustain proliferation at the expense
of differentiation in these constructs. Further, myostatin a negative regu-
lator of skeletal muscle mass (McPherron & Lee, 1997) that reportedly
blocks differentiation of myoblasts into myotubes by reducing myoD, my-
ogenin and protein synthetic pathways via Akt in C2C12 myotubes
(McFarlane et al., 2006) and human skeletal myoblasts (Trendelenburg
et al., 2009) mirrors the profile of expression of TNF and is also increased
at 7 days. Therefore, may be involved in the lack of differentiation
observed. However, the data suggesting a link between myostatin and
the degeneration of skeletal muscle with ageing are controversial, with
some evidence for a contributing role (Leger et al., 2008) and some refut-
ing this role (Ratkevicius et al., 2011) and thus requires further investiga-
tion especially because of its potential therapeutic role in reversing other
muscle wasting conditions in rodents (Whittemore et al., 2003).
Finally, the MPD cells once seeded into the collagen matrices showed
reduced peak force measured over the first 24 h after seeding and
reduced bowing. This was also accompanied with an early inability to
produce MMPs 2 and 9, which have previously been implicated in muscle
cellular ability to remodel the extracellular environment to migrate and
differentiate (Lewis et al., 2000; Morgan et al., 2010). This would
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suggest that the MPD cells cannot adequately remodel the matrix to align
and fuse as efficiently as the parental control cells. With ageing, especially
following damage it could be hypothesized that the ability of the cells to
attach and remodel the matrix may contribute to the inability to regener-
ate and may even precede and thus hamper fusion capacity. Therefore,
muscle ageing requires closer examination with regard to MMPs and even
integrin and vinclulin changes in this model, in both muscle cells isolated
from elderly individuals and from whole tissue, as there is a distinct lack
of investigation. Especially in light of evidence suggesting relaxin overex-
pression can increase MMP activity and regeneration in old mice (Mu
et al., 2010). Elderly individuals also display reduced rate of force devel-
opment (Degens et al., 2009) and force per cross sectional area of muscle
(Morse et al., 2005b) potentially owing to the muscles efficiency of force
transfer through the extracellular matrix, that maybe influenced by levels
of MMP’s.
Conclusion
In vitro three-dimensional (3D) bioengineered collagen constructs that
incorporate multiple population doubled myoblasts under uniaxial ten-
sion, display myotube hampered hypertrophy vs. their parental control
cells. Thus, by using 3D bioengineered collagen constructs these cells can
be used to create an aligned myotube system that has morphologically
atrophied myotubes to parental constructs, modelling aged ⁄ atrophied
skeletal muscle in-vivo. These constructs also display reduced peak force
development upon attachment, and reduced construct bowing, reduced
matrix remodelling potential (reduced MMP2 and MMP9 mRNA expres-
sion), with reduced hypertrophic potential (reduced myogenin, IGF-I, IGF-
IR, IGF-IEa, MGF and increased IGFBP2 mRNA) and finally increased
expression of catabolic transcripts (myostatin and TNF-a). All of which
have been shown to be altered during degeneration of skeletal muscle
with age measured in both isolated muscle derived cells or tissue from
muscle biopsies. This in vitro bioengineered model therefore provides an
aged ⁄ atrophied system that can be experimentally manipulated by
pharmacological, gene and ‘exercise’ therapies (mechanical stretch and
electrical stimulation) to further investigate the cellular and molecular
mechanisms for reduced regeneration observed with ageing in conjunc-
tion with therapeutic interventions.
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